Introduction
If you’re approaching or going through menopause, chances are you’ve heard about hot flushes, mood swings, and sleep issues. But what many women don’t realise is that menopause also marks a turning point for heart health.
In fact, heart disease becomes the leading cause of death for women after menopause, a statistic that’s rarely talked about.
In this blog, we’ll explore the connection between oestrogen, menopause, and the heart, why World Heart Day matters, and how newer treatments like Wegovy (semaglutide) may help reduce the risk of heart disease.
Let’s dive in, because understanding your body means protecting your future.
What Happens to the Heart After Menopause?
Oestrogen’s Protective Role
Before menopause, women have a natural advantage: higher oestrogen levels. Oestrogen helps keep blood vessels flexible, supports good cholesterol (HDL), and reduces the build-up of plaque in the arteries. In other words, it acts like a bodyguard for your heart.
But when oestrogen drops during menopause, that protective layer disappears.
According to the British Heart Foundation, after menopause:
- Women’s risk of high blood pressure increases
- Cholesterol levels may rise
- Arteries may become stiffer and more prone to damage
(BHF, 2023)
It’s not just about ageing, hormonal changes are a key part of the picture.
Why Heart Disease Affects Postmenopausal Women More
After menopause:
- The risk of heart attack rises significantly, and by age 60, a woman’s risk is almost equal to a man’s (NHS, 2024)
- Symptoms may be different from men’s, including fatigue, nausea, jaw pain, or breathlessness — which can delay diagnosis
- Type 2 diabetes, which is more common after midlife, further increases cardiovascular risk
All of this means we need to start thinking about heart health as an essential part of women’s health — not just something for “later in life.”
Hormone Replacement Therapy (HRT): Does It Help?
Hormone Replacement Therapy (HRT) is often used to manage menopause symptoms, and many wonder if it can also protect the heart.
Here’s what we know:
- HRT may offer some cardiovascular benefits when started close to the time of menopause, especially in women under 60 or within 10 years of their last period (NICE, 2023)
- However, HRT is not prescribed solely for heart disease prevention
- Oral HRT and certain risk factors (like smoking or clotting issues) need to be discussed with your GP before starting
So while HRT can be part of the puzzle, it’s not a one-size-fits-all solution.
World Heart Day: Why It Matters
Every year on 29th September, World Heart Day reminds us of something simple but powerful: your heart health is in your hands.
The day aims to raise awareness about cardiovascular disease, encourage early prevention, and educate people around the world, especially women, who are often underdiagnosed or overlooked.
Here’s why it’s important:
- Cardiovascular disease is responsible for 35% of female deaths globally (World Heart Federation, 2024)
- Many women don’t realise their symptoms are heart-related
- Prevention through lifestyle, early screening, and treatment can save lives
Taking part in awareness campaigns, speaking to your doctor, and sharing your story can all make a difference, for you and for others.
What About Wegovy and Heart Health?
You may know Wegovy (semaglutide) as a weight loss injection, but research now shows it also plays a major role in protecting your heart.
In 2024, the FDA approved Wegovy for reducing the risk of heart attack, stroke, and cardiovascular death in adults with obesity and existing heart disease — even those without diabetes (FDA, 2024).
Here’s why this matters for women:
- Excess weight after menopause increases cardiovascular risk
- Losing 5–10% of body weight can significantly lower blood pressure, cholesterol, and blood sugar
- Wegovy has been shown in trials (like the SELECT study) to reduce major heart events by 20% (NEJM, 2023)
And importantly, Wegovy doesn’t interfere with oral HRT or birth control, making it a safe option for many postmenopausal women (Semaglutide Prescribing Information, 2024).
It’s not a substitute for healthy habits, but for many, it can be a game-changer.
What Can You Do to Support Your Heart?
Here are simple, research-backed tips to take control of your heart health during and after menopause:
- ✅ Stay active: Aim for 30 minutes of moderate movement 5 days a week
- ✅ Eat a heart-friendly diet: Think Mediterranean, lots of veggies, oily fish, whole grains, and healthy fats
- ✅ Don’t ignore symptoms: Unusual tiredness, shortness of breath, or jaw pain? Talk to your doctor
- ✅ Know your numbers: Get regular checks on blood pressure, cholesterol, and blood sugar
- ✅ Ask about treatment options: Whether it’s HRT, statins, or Wegovy, personalised care matters
Conclusion
Menopause marks a major shift in your hormones, but it also signals the time to start prioritising your heart health. By understanding the impact of oestrogen, staying informed about tools like HRT and Wegovy, and using moments like World Heart Day to reflect and learn, you’re taking powerful steps toward protecting your future.
Remember, it’s never too early (or too late) to take your heart seriously.
Talk to your healthcare provider, know your options, and keep learning. Your heart deserves it.
References
1. British Heart Foundation (BHF).
“Women and heart disease.” www.bhf.org.uk, 2023. Accessed August 2025.
2. NHS.
“Coronary heart disease in women.” www.nhs.uk, 2024. Accessed August 2025.
3. National Institute for Health and Care Excellence (NICE).
“Menopause: diagnosis and management.” NICE Guidelines NG23, Updated 2023. Available at: www.nice.org.uk.
4. World Heart Federation.
“World Heart Day Facts 2024.” www.world-heart-federation.org, Accessed August 2025.
5. FDA (U.S. Food & Drug Administration).
“FDA approves Wegovy to reduce heart attack, stroke risk.” www.fda.gov, March 2024.
6. SELECT Trial Research Team.
“Semaglutide and cardiovascular outcomes.” New England Journal of Medicine, 2023; 389:1213–1223.